Stock listing

6Z4 Stock Price, News, Filings & Events — Crinetics Pharmaceuticals, Inc.

Selected listing: 6Z4 · MUN · EUR · DE

The 6Z4:MUN listing represents Crinetics Pharmaceuticals, Inc., a biopharmaceutical company focused on developing innovative therapies for rare endocrine diseases and metabolic disorders. The company is actively advancing its pipeline of drug candidates and has been involved in recent clinical trials that may impact its market position. Investors can find updates on the latest news, regulatory filings, and upcoming events related to Crinetics Pharmaceuticals on this page. The market context surrounding the company reflects ongoing interest in its specialized therapeutic areas and potential growth opportunities.

6Z4:MUNEURDEUpdated July 24, 2026
Crinetics Pharmaceuticals, Inc. logo
Ticker
6Z4:MUN
Asset type
Stock
Market cap
$8.87B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
MUN
Currency
EUR

Crinetics Pharmaceuticals, Inc. 6Z4:MUN stock context

The 6Z4:MUN listing represents Crinetics Pharmaceuticals, Inc., a biopharmaceutical company focused on developing innovative therapies for rare endocrine diseases and metabolic disorders. The company is actively advancing its pipeline of drug candidates and has been involved in recent clinical trials that may impact its market position. Investors can find updates on the latest news, regulatory filings, and upcoming events related to Crinetics Pharmaceuticals on this page. The market context surrounding the company reflects ongoing interest in its specialized therapeutic areas and potential growth opportunities.

Research Crinetics Pharmaceuticals, Inc.

Alternate listings